Lurbinectedin and Tarlatamab in ES-SCLC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Lurbinectedin and Tarlatamab in ES-SCLC | Targeted Oncology - Immu…
5 months ago
targetedonc.com
Evaluating the Cost-Effectiveness of Immunotherapy in Lung Cancers | CancerNetwork
Evaluating the Cost-Effectiveness of Immunotherapy in Lung Cancers | …
2 months ago
cancernetwork.com
Practice-Changing Approvals in SCLC: Durvalumab Consolidation and Tarlatamab for Relapsed Disease
Practice-Changing Approvals in SCLC: Durvalumab Consolidation …
Jan 6, 2025
vumedi.com
ES-SCLC Paradigm Change Following IMpower133 and CASPIAN Trials: What Is the Role of Durvalumab in 1L Setting? How Does the Addition of Atezolizumab to CP/ET Affect Patient Outcomes?
ES-SCLC Paradigm Change Following IMpower133 and CASPI…
636 viewsAug 17, 2020
vumedi.com
Immunotherapy: Changing Patient Outcomes in SCLC
Immunotherapy: Changing Patient Outcomes in SCLC
Jul 1, 2019
reachmd.com
ES-SCLC 1L Systemic Therapy Updates
ES-SCLC 1L Systemic Therapy Updates
389 views1 year ago
vumedi.com
Extensive-Stage Small Cell Lung Cancer Treatment | TECENTRIQ® (atezolizumab)
6:14
Extensive-Stage Small Cell Lung Cancer Treatment | TECENTRIQ® (…
Dec 18, 2023
tecentriq.com
A New Immunotherapy for Bladder Cancer
Dec 29, 2019
aacr.org
9:15
ADRIATIC Trial: Durvalumab, cCRT Timing, and Survival in LS-SCLC | …
Jun 25, 2024
onclive.com
Durvalumab in LS-SCLC: Exploring Phase 3 ADRIATIC Trial Outcome…
Oct 7, 2024
onclive.com
Guidelines for Managing Chemo-Induced Myelosuppression in ES-…
Sep 2, 2021
onclive.com
Using Trilaciclib for Treatment of ES-SCLC | OncLive
Apr 2, 2021
onclive.com
Management of ES-SCLC: Second Line and Beyond | OncLive
Apr 2, 2021
onclive.com
ES-SCLC: Trilaciclib for Chemo-Induced Myelosuppression | OncL…
Sep 9, 2021
onclive.com
AEGEAN: A Phase 3 Trial of Neoadjuvant Durvalumab Chemot…
May 19, 2023
onclive.com
1:30
Dr Shields on Incorporating Tarlatamab into Clinical Practice f…
Jul 30, 2024
onclive.com
ESMO 2024 Insights: CCTG BR.31 - Adjuvant Durvalumab in Complete…
26 viewsOct 22, 2024
vumedi.com
ES-SCLC Treatment Decisions: Expert Insights into Clinical Trial …
9 months ago
onclive.com
ELCC 2025 Insights: Patient-Reported Outcomes With Perioper…
Apr 22, 2025
vumedi.com
NSCLC Care: Evaluating Durvalumab in the First-Line Setting
Dec 28, 2023
reachmd.com
12:40
Real-world comparison of the efficacy and safety of atezolizuma…
Dec 17, 2024
onclive.com
24:24
Durvalumab ± Tremelimumab Chemotherapy in First-Line Metast…
Feb 26, 2024
onclive.com
40:01
Emerging Nuances of Extensive-Stage SCLC Treatment: Individuali…
2 weeks ago
YouTubePeerVoice
3:46
Understanding Immunotherapy for Lung Cancer
37.1K viewsAug 6, 2020
YouTubeYou and Lung Cancer
27:08
Immunotherapy Advances in Small Cell Lung Cancer
35.1K viewsNov 28, 2018
YouTubeCancer Research Institute
2:52
Immunotherapy Treatments for Small Cell Lung Cancer (SCLC)
15.3K viewsAug 6, 2020
YouTubeYou and Lung Cancer
3:30
Immunotherapy Treatments for Non-Small Cell Lung Cancer (NSCLC)
83.5K viewsAug 6, 2020
YouTubeYou and Lung Cancer
2:38
First-Line Carboplatin and Pemetrexed With Pembrolizumab f…
5K viewsJun 20, 2017
YouTubeTargeted Oncology
2:47
The Mechanism of Action of Immunotherapy for Cancer Treatm…
22.3K viewsJul 30, 2020
YouTubeScientific Animations
10:09
ESMO 2020 Expert Video Report on long term ICI outcomes in lung ca…
1.1K viewsSep 30, 2020
YouTubeEuropean Society for Medical Oncology (ESMO)
See more videos
Static thumbnail place holder